While it has never been named in a Biomet hip recall, at least $56 million has been paid to resolve hundreds of lawsuits involving Biomet M2a Magnum hip implants.
The nationwide law firm of Bernstein Liebhard LLP represents individuals who suffered serious complications allegedly associated with Biomet, Inc.’s metal-on-metal M2a Magnum hip system. If you experienced metallosis, psuedotumor formation or other problems that resulted in premature failure of your Biomet hip, please call (888) 994-5118.
The Biomet M2a Magnum metal-on-metal hip replacement system consists of a large metal head made from a cobalt, chromium, and molybdenum alloy. The porous coating and taper adapter is constructed of a titanium alloy believed to aid in bone growth. Biomet promised that this metal-on-metal design would provide younger, more active patients with a longer-lasting hip, as well as greater flexibility and range of motion.
Unfortunately, metal-on-metal hips like the Biomet M2a Magnum have been associated with hundreds of reported complications, including tissue necrosis (death), the formation of pseudotumors, metallosis, adverse local tissue reactions, groin pain, swelling, and loosening of the implant leading to dislocation or fracture. These injuries appear to the result of the toxic metal ions shed by the hip when the metal components rub together.
In 2011, the U.S. Food & Drug Administration (FDA) began reviewing metal-on-metal hip implants amid concerns that particles shed by the devices can result in an adverse local tissue reaction that causes damage to bone and/or tissue surrounding the implant and joint. There have also been some medical case reports of patients in which high levels of metal ions in the bloodstream may have caused symptoms or illnesses elsewhere in the body, including the heart, nervous system, and thyroid gland, the agency said.
In January 2013, the FDA issued new guidance regarding this class of devices, and advised doctors to consider metal ion testing if patients are experiencing symptoms of hip implant failure. Read More
While some metal-on-metal hip manufacturers have pulled their devices from the market, there has never been a Biomet hip recall for any device included the M2a Magnum hip line. However, this does not preclude recipients of this artificial hip from pursuing legal action for any injuries or complications they allegedly sustained due to its all-metal design. In fact, more than 1,900 product liability lawsuits have been filed in U.S. courts that involve M2a Magnum hip replacements.
In February 2014, Biomet agreed to pay $56 million to settle many of these claims. Cases eligible for the settlement program include those filed on or before April 15, 2014. Plaintiffs who received one of the affected Biomet hip replacements as part of an initial surgery that was rectified more than 180 days after it was implanted will be eligible for a base award of $200,000. Read More
Recipients a failed M2a Magnum hip may be eligible for financial compensation, even in the absence of a Biomet hip recall. To learn more, please call (888) 994-5118.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.